Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calmagrip Forte
- Development stage
- Unknown
- Lead developer
- Pharmex Group
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Calmagrip Forte is an oral combination medication developed and marketed by Pharmex Group for the symptomatic relief of common cold and influenza symptoms. It contains three active ingredients: paracetamol (650 mg), which acts as an analgesic and antipyretic; caffeine (25 mg), which serves as a central nervous system stimulant and adjuvant to enhance paracetamol's effects; and chlorphenamine maleate (4 mg), an H1 antihistamine that alleviates allergic symptoms such as sneezing, tearing, and nasal congestion. The product is approved in Spain for treating fever, mild to moderate pain, and catarrhal processes associated with the common cold and flu.
- Brand names
- Calmagrip Forte
- Other names
- Paracetamol/Caffeine/Chlorphenamine 650mg/25mg/4mgparacetamol + caffeine + chlorphenamine
02
Targets
ADORA1 (Adenosine receptor A1 subtype)ADORA2A (Adenosine A₂A Receptor)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)HRH1 (Histamine H1 Receptor)
Beyond the preview
Go deeper on Calmagrip Forte.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Calmagrip Forte.